Sandor Victor Insider Trades

Insider Trading History

Track insider trading activity for Sandor Victor. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Merus N.V
Merus N.V MRUS
Director
Holding Value $0 0 shares
Last Trade
Dec 12, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$8.22M 84,806 shares
$96.91
$90.00
Prelude Therapeutics
Prelude Therapeutics PRLD
Director
Holding Value $444k 121,285 shares
Last Trade
Nov 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$169k 121,285 shares
$1.39
$3.66
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $1.17M 16,000 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$744k 16,000 shares
$46.47
$73.21
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $334k 108,286 shares
Last Trade
Jun 13, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$45.1k 12,600 shares
$3.58
$3.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Director
Holding Value $139k 38,000 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.5k 38,000 shares
$1.04
$3.66
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $372k 120,886 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$144k 40,000 shares
$3.59
$3.08
Merus N.V
Merus N.V MRUS
Director
Holding Value $1.19M 13,193 shares
Last Trade
May 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$549k 13,193 shares
$41.60
$90.00
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $1.17M 16,000 shares
Last Trade
Jun 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$499k 16,000 shares
$31.20
$73.21
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $249k 80,886 shares
Last Trade
Jun 17, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$20.2k 6,995 shares
$2.89
$3.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Director
Holding Value $86k 23,500 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91.7k 23,500 shares
$3.90
$3.66
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $271k 87,881 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$126k 40,000 shares
$3.16
$3.08
Merus N.V
Merus N.V MRUS
Director
Holding Value $796k 8,844 shares
Last Trade
May 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$431k 8,844 shares
$48.73
$90.00
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $147k 47,881 shares
Last Trade
Jan 02, 2024 Sale
$52.6k 31,112 shares
$1.69
$3.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Director
Holding Value $86k 23,500 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$131k 23,500 shares
$5.56
$3.66
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $879k 12,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$332k 12,000 shares
$27.67
$73.21
Merus N.V
Merus N.V MRUS
Director
Holding Value $1.3M 14,414 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$336k 14,414 shares
$23.29
$90.00
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $1.76M 24,000 shares
Last Trade
Nov 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$742k 24,000 shares
$30.92
$73.21
Prelude Therapeutics
Prelude Therapeutics PRLD
Director
Holding Value $126k 34,300 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$163k 34,300 shares
$4.74
$3.66
Merus N.V
Merus N.V MRUS
Director
Holding Value $1.49M 16,604 shares
Last Trade
May 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$308k 16,604 shares
$18.56
$90.00
Prelude Therapeutics
Prelude Therapeutics PRLD
Director
Holding Value $41k 11,206 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$148k 11,206 shares
$13.22
$3.66

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up